PMC:7294857 / 29580-30239
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T338 | 110-115 | UBERON:0000170 | denotes | lungs |
T339 | 185-193 | UBERON:0003215 | denotes | alveolar |
T340 | 224-231 | UBERON:0002185 | denotes | bronchi |
T341 | 233-245 | GO:0003406 | denotes | formation of |
T342 | 264-282 | CL:0009002 | denotes | inflammatory cells |
T343 | 327-335 | UBERON:0003215 | denotes | alveolar |
T344 | 336-346 | UBERON:0000483 | denotes | epithelium |
T345 | 414-424 | DG_28 | denotes | remdesivir |
T346 | 429-438 | DG_23 | denotes | lopinavir |
T347 | 440-452 | DG_6;CHEBI:28619;CHEBI:28619 | denotes | azithromycin |
T348 | 454-472 | DG_20;CHEBI:5801;CHEBI:5801 | denotes | hydroxychloroquine |
T349 | 517-523 | UBERON:0001969 | denotes | plasma |
T45524 | 110-115 | UBERON:0000170 | denotes | lungs |
T45563 | 185-193 | UBERON:0003215 | denotes | alveolar |
T53938 | 224-231 | UBERON:0002185 | denotes | bronchi |
T28623 | 233-245 | GO:0003406 | denotes | formation of |
T30220 | 264-282 | CL:0009002 | denotes | inflammatory cells |
T33548 | 327-335 | UBERON:0003215 | denotes | alveolar |
T24524 | 336-346 | UBERON:0000483 | denotes | epithelium |
T61537 | 414-424 | DG_28 | denotes | remdesivir |
T75915 | 429-438 | DG_23 | denotes | lopinavir |
T4102 | 440-452 | DG_6;CHEBI:28619;CHEBI:28619 | denotes | azithromycin |
T81210 | 454-472 | DG_20;CHEBI:5801;CHEBI:5801 | denotes | hydroxychloroquine |
T55761 | 517-523 | UBERON:0001969 | denotes | plasma |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T95 | 110-115 | Body_part | denotes | lungs | http://purl.org/sig/ont/fma/fma68877 |
T96 | 185-193 | Body_part | denotes | alveolar | http://purl.org/sig/ont/fma/fma264783 |
T97 | 277-282 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T98 | 327-346 | Body_part | denotes | alveolar epithelium | http://purl.org/sig/ont/fma/fma63915 |
T99 | 336-346 | Body_part | denotes | epithelium | http://purl.org/sig/ont/fma/fma9639 |
T100 | 517-523 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T45 | 224-231 | Body_part | denotes | bronchi | http://purl.obolibrary.org/obo/UBERON_0002185 |
T46 | 336-346 | Body_part | denotes | epithelium | http://purl.obolibrary.org/obo/UBERON_0000483 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T193 | 110-115 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lungs |
T194 | 254-262 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T195 | 277-282 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T196 | 336-346 | http://purl.obolibrary.org/obo/UBERON_0000483 | denotes | epithelium |
T197 | 517-523 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T198 | 560-565 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focus |
T199 | 636-637 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T88 | 398-408 | Chemical | denotes | antivirals | http://purl.obolibrary.org/obo/CHEBI_22587 |
T89 | 414-424 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T90 | 429-438 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T91 | 440-452 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
T92 | 454-472 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T99 | 179-202 | Phenotype | denotes | ffuse alveolar damage, | http://purl.obolibrary.org/obo/HP_0033006 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T21 | 233-242 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T245 | 0-659 | Sentence | denotes | Frequently seen radiological and pathological findings are bilateral ground-glass opacities in peripheries of lungs, consolidations, crazy paving pattern, air bronchogram sign, diffuse alveolar damage, fibrinous exudates in bronchi, formation of hyaline membrane, inflammatory cells infiltration, and metaplastic change in the alveolar epithelium. There is no definitive treatment, but the role of antivirals like remdesivir and lopinavir, azithromycin, hydroxychloroquine, and passive immunization like convalascent plasma is being researched. Currently, the focus is on the prevention of disease by practicing social distancing until a vaccine is developed. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
728 | 414-424 | Chemical | denotes | remdesivir | MESH:C000606551 |
729 | 429-438 | Chemical | denotes | lopinavir | MESH:D061466 |
730 | 440-452 | Chemical | denotes | azithromycin | MESH:D017963 |
731 | 454-472 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
739 | 185-200 | Disease | denotes | alveolar damage | MESH:D055370 |